875 results match your criteria: "Dermatologic Manifestations of Hematologic Disease"
Cancer Rep (Hoboken)
December 2024
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cancer Rep (Hoboken)
November 2024
Student Research Committee, Clinical Research Development Unit of Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.
Rev Med Inst Mex Seguro Soc
March 2024
Instituto Mexicano del Seguro Social, Hospital General de Zona No. 47 Vicente Guerrero, Servicio de Medicina Interna. Ciudad de México, México.
Biology (Basel)
August 2024
Department of Internal Medicine and Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
J Med Case Rep
September 2024
Colombo North Teaching Hospital, Ragama, Sri Lanka.
Nephrology (Carlton)
November 2024
Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
Pan Afr Med J
September 2024
Department of Clinical Hematology and Bone Marrow Transplantation, University Hospital Centre Mohammed VI, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakesh, Morocco.
Cureus
July 2024
Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Leuk Res
October 2024
National Cancer Institute, Bratislava, Slovakia, Oncohematology Department, Slovakia; Faculty of Medicine Comenius University, Slovakia.
Ann Hematol
November 2024
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome is caused by mutations in the UBA1 gene in myeloid precursors, leading to systemic inflammatory manifestations. We present the case of a 75-year-old man presenting with fever, panniculitis, and macrocytic anemia testing repeatedly negative for UBA1 mutations in peripheral blood samples, but ultimately found positive on bone marrow mononuclear cell DNA. The man has been successfully treated with prednisone and methotrexate.
View Article and Find Full Text PDFFront Immunol
August 2024
Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Clin J Gastroenterol
October 2024
Division of Gastroenterology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
J Investig Allergol Clin Immunol
July 2024
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children´s Medical Center, Tehran University of Medical Science, Tehran, Iran.
Saudi Med J
August 2024
From the College of Medicine (Altammami, Alswayed, AlJasser, Alkhodair), King Saud bin Abdulaziz University for Health Sciences, from the Department of Dermatology (AlJasser, Alkhodair), King Abdullah International Medical Research Center, from the Division of Dermatology (AlJasser), Ministry of National Guard Health Affairs, and from the Division of Pediatric Dermatology (Alkhodair), Department of Pediatrics, King Abdullah Specialist Children's Hospital, Riyadh, Kingdom of Saudi Arabia.
Lasers Surg Med
September 2024
Department of Dermatology, University of California, Irvine, Irvine, California, USA.
Arch Dermatol Res
June 2024
Department of Biosciences, Universidad de La Sabana, Campus Puente Común, Km. 7, Autopista Norte de Bogotá, Chía, Colombia.
R I Med J (2013)
July 2024
Warren Alpert Medical School of Brown University, Rhode Island Hospital, Department of Hematology and Oncology, Providence, R.
J Assoc Physicians India
November 2023
Junior Resident, Department of General Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India, Corresponding Author.
Liver Int
August 2024
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ann Hematol
October 2024
Division of Hematology and Medical Oncology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road Mail Code: OC14HO, 97239, Portland, OR, USA.
Acta Med Indones
January 2024
Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia.
Front Pharmacol
March 2024
Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Minocycline is a tetracycline commonly used for several dermatological diseases. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe adverse event which can be caused by minocycline. An 18-year-old male patient developed fever, acute rash, pharyngeal pain, lymphadenopathy, hematologic abnormalities, increased creatinine level, elevated liver enzyme levels, and splenomegaly 4 weeks after the oral treatment of minocycline, 100 mg daily, for acne.
View Article and Find Full Text PDFTransplant Cell Ther
June 2024
Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Int J Hematol
May 2024
Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Arthritis Res Ther
March 2024
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.